Surgery · Breast (Benign, Carcinoma Breast, Staging, Treatment)

The ACOSOG Z0011 trial changed surgical practice for sentinel node biopsy in breast cancer. Which of the following best summarizes its landmark conclusion?

  • A Axillary lymph node dissection is mandatory when any sentinel node is positive
  • B Sentinel node biopsy is contraindicated after neoadjuvant chemotherapy
  • C Completion axillary dissection improves overall survival when sentinel nodes show micrometastases
  • D In T1-T2 tumors with 1-2 positive sentinel nodes treated with breast-conserving surgery and whole-breast radiation, axillary dissection can be omitted
Correct answer: D. In T1-T2 tumors with 1-2 positive sentinel nodes treated with breast-conserving surgery and whole-breast radiation, axillary dissection can be omitted

Explanation

ACOSOG Z0011 (Giuliano et al., JAMA 2011) demonstrated that for patients with T1-T2 clinically node-negative breast cancer with 1–2 positive sentinel lymph nodes who underwent breast-conserving surgery plus whole-breast radiation, axillary lymph node dissection provided no survival benefit over sentinel node biopsy alone. This trial significantly reduced the use of completion axillary dissection in suitable patients.

Reference: Bailey & Love's Short Practice of Surgery, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Breast (Benign, Carcinoma Breast, Staging, Treatment) MCQs

See all Breast (Benign, Carcinoma Breast, Staging, Treatment) MCQs →